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The immune system employs intricate 
mechanisms to maintain self-tolerance; 
these  regulatory  mechanisms  ensure 
that immune cells distinguish foreign 
invaders from healthy tissues. To en-
sure self-tolerance in T cells, an entire 
organ (the thymus) is devoted to se-
lecting specific thymocytes that are able 
to recognize major histocompatability 
complex (MHC)–self-peptide antigens 
while deleting thymocytes that recognize 
these complexes too strongly. Analo-
gous regulatory mechanisms are in place 
to assure self-tolerance during the de-
velopment of B cells in the bone mar-
row. Natural killer (NK) cells are no 
exception and also undergo an education 
process during development whereby 
cells that are potentially self-reactive are 
rendered anergic.
NK cells, which were first described 
by several groups in the early 1970s 
(Greenberg et al., 1973; Herberman   
et al., 1975; Kiessling et al., 1975; Sendo 
et al., 1975; Zarling et al., 1975), circu-
late through the blood and lymphatics 
and reside in virtually all organs. In 
these tissues, NK cells are poised to 
eliminate stressed, virally infected, or 
transformed cells without prior sensi-
tization  while  minimizing  injury  to 
normal healthy cells. In humans and 
mice, NK cells survey their environ-
ment by using a sophisticated repertoire 
of evolutionarily selected activating and 
inhibitory receptors that bind both host- 
and pathogen-encoded ligands (Lanier, 
2005). Because NK cells are powerful 
effector lymphocytes, their activation 
must be tightly regulated to ensure 
that NK cells protect the host from 
pathogen invasion while avoiding del-
eterious autoimmune responses. Thus, 
during their development in the bone 
marrow, NK cells are trained, or “ed-
ucated,” to distinguish healthy from 
abnormal tissues.
Education and self-tolerance  
of NK cells
In 1986, Kärre et al. (1986) observed 
that unlike T cells, which respond to 
foreign protein components bound to 
MHC molecules, NK cells attack cells 
that  are  “missing  self,”  i.e.,  lacking 
MHC molecules. The missing self hy-
pothesis inferred that an NK cell had to 
possess inhibitory receptors that could 
bind MHC class I (expressed on vir-
tually  all  healthy  cells),  thereby  pre-
venting the NK cell from becoming 
activated during normal healthy con-
ditions (Ljunggren and Kärre, 1990).   
A couple of years later, Karlhofer et al. 
(1992)  provided  the  first  molecular 
evidence for the missing self hypothesis 
by identifying an inhibitory receptor 
(Ly49A on mouse NK cells) that spe-
cifically  recognizes  MHC  class  I  and 
suppresses NK cell function. At the 
same time, amino acid residues in human 
MHC class I that specifically rendered 
target cells resistant to NK cell–mediated 
cytotoxicity were identified (Storkus 
et al., 1991). Soon thereafter, several 
groups identified and cloned the genes 
encoding  human  inhibitory  NK  cell 
receptors that recognize different HLA 
class I family members (Colonna and 
Samaridis, 1995; D’Andrea et al., 1995; 
Gumperz et al., 1995; Wagtmann et al., 
1995). The responsible inhibitory re-
ceptors were designated the killer cell 
immunoglobulin-like receptor (KIR) 
family (Long et al., 1996). Later studies 
demonstrated that in addition to sens-
ing a loss of MHC class I in target cells, 
full effector function of NK cells requires 
triggering of their activating receptors 
via stress-induced or virus-encoded li-
gands on target cells (Cerwenka et al., 
2001; Diefenbach et al., 2001; Arase 
et al., 2002; Smith et al., 2002). These 
studies explain the inability of NK cells 
to attack healthy cells that display either 
no MHC class I (e.g., erythrocytes) or 
low levels of MHC class I (e.g., neu-
rons) on their surface. Although NK 
cells have been studied for several de-
cades, the activating NK cell receptors 
and ligands responsible for mediating 
“missing self” rejection of MHC class I–
deficient cells remains elusive.
During development, NK cells have 
been shown to transit through several 
distinct stages, which are defined by 
acquisition of function and expression 
of surface receptors (Yokoyama et al., 
2004; Di Santo, 2006). Immature mouse 
NK cells begin to express inhibitory 
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is evidence that NK cells can also de-
velop in peripheral organs, including 
the thymus (Vosshenrich et al., 2006), 
and possibly in human lymph nodes 
(Freud et al., 2005). There is also evi-
dence that NK cells continue to mature 
after egress from the bone marrow, as 
splenic NK cell populations consist of 
cells displaying varying degrees of mat-
uration  (which  correlate  with  their 
expression of markers such as CD27, 
Mac-1, and KLRG1; Hayakawa and 
Smyth, 2006; Huntington et al., 2007a; 
Chiossone et al., 2009). In studies pub-
lished in this issue, Joncker et al. and 
Elliot et al. find that the ability of ma-
ture NK cells to produce IFN- and 
kill target cells can be reprogrammed 
after the cells are exposed to MHC class I 
environments different than the ones 
in which they developed. In these stud-
ies, splenic NK cells that matured in   
a MHC class I–sufficient environment 
and acquired full effector function were 
adoptively transferred into a new host 
that was devoid of MHC class I. Sur-
prisingly, these mature NK cells became 
anergic to receptor stimulation within 
several days after adoptive transfer into 
the  MHC  class  I–deficient  recipient 
(Fig. 1 D). In the reciprocal experiment, 
unresponsive  NK  cells  from  MHC 
class I–deficient mice were adoptively 
transferred into MHC class I–sufficient 
hosts (either in high numbers, or into 
an NK cell–deficient host strain to avoid 
rejection); these transferred cells gained 
effector function (Fig. 1 E). Like wild-
type NK cells, these previously anergic 
NK  cells  now  produced  high  levels   
of  IFN-  and  degranulated  robustly 
when various activating receptors were 
triggered ex vivo.
Previous data suggested that the ed-
ucation of NK cells is restricted to the 
bone marrow (Yokoyama et al., 2004; 
Huntington  et  al.,  2007b).  However, 
these new studies indicate that develop-
mental programming in NK cells is not 
entirely fixed, and that mature NK cells 
can be “re-educated,” gaining or losing 
functional capacity as their new envi-
ronment dictates. It will be interesting 
to learn where the reprogramming is 
occurring. It remains to be determined 
whether adoptively transferred mature 
rendered hyporesponsive (Anfossi et al., 
2006; Yu et al., 2007; Kim et al., 2008). 
The education of NK cells is also influ-
enced by signals received through acti-
vating receptors. In a process analogous 
to  negative  selection  of  developing   
T cells, ligation of activating receptors on 
developing NK cells by ubiquitiously 
expressed cognate viral or self-ligands 
leads to both a repression of cellular 
function  through  that  particular  re-
ceptor and a partial deletion of the sub-
set repertoire (Ogasawara et al., 2005; 
Oppenheim et al., 2005; Sun and Lanier, 
2008b; Tripathy et al., 2008). Alto-
gether, these mechanisms are thought 
to exist to ensure that mature NK cells 
do not attack healthy self-tissues.
Re-education of NK cells
Although NK cell precursors are pri-
marily found in the bone marrow, there 
Ly49 receptors early in development; this 
initiates an education process whereby 
inhibitory Ly49 receptor engagement 
of autologous MHC class I results in the 
generation of functional effector NK 
cells in the periphery (Fig. 1 A; Fernandez 
et al., 2005; Kim et al., 2005). This se-
lection process has been termed “licens-
ing” or “arming” of NK cells. Failure 
to engage inhibitory receptors during 
development, due to lack of inhibitory 
receptor expression on the NK cell or 
lack of interaction with MHC class I, 
results in the generation of a subset of 
anergic or hyporesponsive peripheral 
NK cells (Fig. 1, B and C; Fernandez et 
al., 2005; Kim et al., 2005). Similarly, 
human NK cells that express certain in-
hibitory KIRs that engage cognate HLA 
during development gain effector func-
tion; in the absence of inhibitory KIR–
HLA interactions, human NK cells are 
Figure 1.  Education and re-education of NK cells. The figure depicts the “education” of devel-
oping NK cells in different bone marrow environments (left ) and the experimental “re-education” of 
mature NK cells in different peripheral environments (right). (A) Immature NK cells expressing inhibi-
tory receptors that engage MHC class I become responsive mature effector cells. (B) Immature NK 
cells expressing inhibitory receptors that do not engage MHC class I become anergic cells. (C) Imma-
ture NK cells lacking inhibitory receptors that can engage MHC class I also become anergic cells.  
(D) Mature responsive NK cells that are adoptively transferred into a MHC class I–deficient environment 
become anergic. (E) Mature anergic NK cells (expressing inhibitory receptors for MHC class I) that are 
adoptively transferred into a MHC class I–sufficient setting become responsive. (F) During viral infec-
tion and inflammation, mature anergic NK cells (lacking inhibitory receptors for MHC class I) become 
activated and hyperresponsive effector cells.JEM VOL. 207, September 27, 2010 2051
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Greenberg,  A.H.,  L.  Hudson,  L.  Shen,  and 
I.M.  Roitt.  1973.  Antibody-dependent 
NK cells was unable to promote sur-
vival any better than the negative con-
trol receiving no NK cells. Together, 
these  findings  suggest  that  although 
inhibitory  receptors  are  required  for 
self-tolerance, they hinder productive 
immune  responses  during  infection. 
Thus, an overall lack of inhibitory re-
ceptors against autologous MHC class I 
permits NK cells to respond more ro-
bustly against viral infection (Fig. 1 F). 
Perhaps  infection  and  inflammation 
stimulate responsive (licensed) and an-
ergic (unlicensed) NK cells similarly, 
but once the initial threshold for acti-
vation is attained, those NK cells with-
out  inhibiting  receptors  intuitively 
respond faster and more robustly. Al-
though the potential for autoimmunity 
and greater collateral damage resides in 
the unlicensed NK cells, it is possible that 
evolutionary  pressures  have  allowed 
for the selection and maintenance of 
this normally anergic subset specifically 
to deal with infectious pathogens.
In addition, these features may prove 
useful in the setting of allogeneic hema-
topoietic  stem  cell  transplantation  for 
the treatment of leukemia patients. In 
several  independent  studies,  patients 
receiving inhibitory KIR–HLA mis-
matched transplants had a lower inci-
dence of leukemia relapse and a higher 
frequency of survival compared with 
patients receiving NK cell populations 
that could be inhibited by host HLA 
molecules (Hsu et al., 2005; Clausen 
et al., 2007; Miller et al., 2007; Sobecks 
et al., 2007; Yu et al., 2009). A greater 
understanding of how NK cells develop 
and function may advance the preven-
tion and treatment of certain infectious 
diseases and cancers.
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